The Correlation Between Type and Stage of Lung Cancer with The Chronic Obstructive Pulmonary Disease Group at Arifin Achmad Hospital, Pekanbaru
DOI:
https://doi.org/10.36497/jri.v45i2.512Keywords:
COPD, lung cancer, spirometryAbstract
Background: The relationship between lung cancer (LC) and chronic obstructive pulmonary disease (COPD) has been extensively studied but is still up for debate. COPD is a molecularly based illness and one of the independent risk factors for lung cancer, particularly squamous cell carcinoma. This study uses spirometry to assess the relationship between the type and stage of LC and COPD in a group of LC patients at Arifin Achmad Hospital.
Methods: This cross-sectional study was conducted on lung cancer patients in Arifin Achmad Hospital, Pekanbaru, from June 2022 to December 2022. Based on spirometry examination, patients were grouped according to the degree of COPD. Then, the relationship between the COPD group and the type and degree of cancer was determined.
Results: The study involved 52 patients predominantly male (71.2%), aged over 40 years (92.3%), Smokers and former smokers with Severe Brinkman index (69.2%), restrictive lung function (34.6%), COPD group D (40.4%), adenocarcinoma (61.5%), stage IV lung cancer (92,3%) and WHO Performance Status Scale 2 (61.5%). The FEV1/FVC rate in this study was 66.67%. There is a link between the stage of lung cancer and the group of COPD (P=0.001).
Conclusion: There is a relation between the stage of LC in the COPD group, which is predominantly with stage IV lung cancer, and group D of COPD.
Downloads
References
1. Parris BA, O’Farrell HE, Fong KM, Yang IA. Chronic obstructive pulmonary disease (COPD) and lung cancer: common pathways for pathogenesis. J Thorac Dis. 2019;11:S2155–72.
2. Hou W, Hu S, Li C, Ma H, Wang Q, Meng G, et al. Cigarette smoke induced lung barrier dysfunction, EMT, and tissue remodeling: a possible link between COPD and lung cancer. Biomed Res Int. 2019;2019:2025636.
3. Ytterstad E, Moe PC, Hjalmarsen A. COPD in primary lung cancer patients: prevalence and mortality. Int J Chron Obstruct Pulmon Dis. 2016;11:625–36.
4. Choudhury G, Rabinovich R, MacNee W. Comorbidities and systemic effects of chronic obstructive pulmonary disease. Clin Chest Med. 2014;35:101–30.
5. Blanco I, Diego I, Bueno P, Casas-Maldonado F, Miravitlles M. Geographic distribution of COPD prevalence in the world displayed by Geographic Information System maps. Eur Respir J. 2019;54:1900610.
6. Machida H, Inoue S, Shibata Y, Kimura T, Ota T, Ishibashi Y, et al. The incidence and risk analysis of lung cancer development in patients with chronic obstructive pulmonary disease: possible effectiveness of annual CT-screening. Int J Chron Obstruct Pulmon Dis. 2021;16:739–49.
7. Chubachi S, Takahashi S, Tsutsumi A, Kameyama N, Sasaki M, Naoki K, et al. Radiologic features of precancerous areas of the lungs in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2017;12:1613–24.
8. Dai J, Yang P, Cox A, Jiang G. Lung cancer and chronic obstructive pulmonary disease: from a clinical perspective. Oncotarget. 2017;8:18513–24.
9. Tockman MS, Anthonisen NR, Wright EC, Donithan MG. Airways obstruction and the risk for lung cancer. Ann Intern Med. 1987;106.
10. Badan Pusat Statistik. Persentase penduduk berumur 15 tahun ke atas yang merokok tembakau selama sebulan terakhir menurut provinsi (persen), 2021- 2023 [Internet]. 2023 [cited 2023 Apr 20]. Available from: https://www.bps.go.id/id/statistics-table/2/MTQzNSMy/persentase-merokok-%20pada-penduduk-umur%2015-tahun-menurut-%20provinsi--persen-.html
11. Denholm R, Schüz J, Straif K, Stücker I, Jöckel KH, Brenner DR, et al. Is previous respiratory disease a risk factor for lung cancer? Am J Respir Crit Care Med. 2014;190:549–59.
12. Gonzalez J, Marín M, Sánchez-Salcedo P, Zulueta JJ. Lung cancer screening in patients with chronic obstructive pulmonary disease. Ann Transl Med. 2016;4:160.
13. Yunus F. Pemeriksaan spirometri. In: Panduan pemeriksaan spirometri. 1st ed. Jakarta: UI Publishing; 2022. p. 33–52.
14. Chien JW, Au DH, Barnett MJ, Goodman GE. Spirometry, rapid FEV1 decline, and lung cancer among asbestos exposed heavy smokers. COPD. 2007;4:339–46.
15. Zhai T, Li Y, Brown R, Lanuti M, Gainor JF, Christiani DC. Spirometry at diagnosis and overall survival in non-small cell lung cancer patients. Cancer Med. 2022;11:4796.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 di Sarikawan Gurning, Sri Melati Munir, Faisal Yunus, Zarfiardy Aksa Fauzi, Adrianison, Indra Yovi, Sri Indah Indriani
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
- The authors own the copyright of published articles. Nevertheless, Jurnal Respirologi Indonesia has the first-to-publish license for the publication material.
- Jurnal Respirologi Indonesia has the right to archive, change the format and republish published articles by presenting the authors’ names.
- Articles are published electronically for open access and online for educational, research, and archiving purposes. Jurnal Respirologi Indonesia is not responsible for any copyright issues that might emerge from using any article except for the previous three purposes.
